Freedom Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,074
Closed -$247K 906
2021
Q4
$247K Buy
4,074
+226
+6% +$13.4K 0.02% 743
2021
Q3
$216K Buy
+3,848
New +$211K 0.02% 737
2020
Q2
Sell
-6,276
Closed -$288K 662
2020
Q1
$288K Sell
6,276
-381
-6% -$14.8K 0.03% 512
2019
Q4
$270K Sell
6,657
-1,876
-22% -$70K 0.02% 521
2019
Q3
$296K Buy
+8,533
New +$281K 0.03% 514
2019
Q2
Sell
-11,964
Closed -$358K 723
2019
Q1
$358K Buy
+11,964
New +$343K 0.03% 468
2018
Q3
Sell
-12,580
Closed -$483K 946
2018
Q2
$483K Buy
+12,580
New +$424K 0.03% 571
2018
Q1
Sell
-5,339
Closed -$237K 1188
2017
Q4
$237K Buy
5,339
+508
+11% +$23.1K 0.01% 976
2017
Q3
$242K Buy
+4,831
New +$247K 0.01% 942
2017
Q2
Sell
-5,167
Closed -$287K 1111
2017
Q1
$287K Buy
+5,167
New +$285K 0.02% 795
2016
Q2
Sell
-4,937
Closed -$264K 882
2016
Q1
$264K Buy
+4,937
New +$243K 0.02% 603

Other funds holding PBH

Freedom Investment Management's PBH Position: Q1 2022 in Review

Freedom Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2022, closing a stake of 4,074 shares — an estimated $247K sold.

Freedom Investment Management first reported a position in PBH in Q1 2016 and held it in 11 quarters. The position peaked at $483K in Q2 2018. 287 funds tracked by Wall St. Rank hold PBH as of Q1 2022.

  • Freedom Investment Management reported no remaining Prestige Consumer Healthcare position as of Q1 2022 after selling out during the quarter.
  • Freedom Investment Management sold 4,074 Prestige Consumer Healthcare shares in Q1 2022, an estimated $247K.
  • Freedom Investment Management first reported a position in Prestige Consumer Healthcare in Q1 2016 and held it in 11 quarters.
  • Freedom Investment Management's Prestige Consumer Healthcare position peaked at $483K in Q2 2018.
  • 287 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2022.

Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.